CoChat

Telomerase treatment prevents lung profibrotic pathologies associated with physiological aging

Open access
Piñeiro-Hermida, Sergio, Autilio, Chiara, Martínez, Paula, Bosch, Fátima, Pérez-Gil, Jesús, Blasco, Maria A. · 2020 · Journal of Cell Biology

The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.

Abstract

Short/dysfunctional telomeres are at the origin of idiopathic pulmonary fibrosis (IPF) in patients mutant for telomere maintenance genes. However, it remains unknown whether physiological aging leads to short telomeres in the lung, thus leading to IPF with aging. Here, we find that physiological aging in wild-type mice leads to telomere shortening and a reduced proliferative potential of alveolar type II cells and club cells, increased cellular senescence and DNA damage, increased fibroblast activation and collagen deposits, and impaired lung biophysics, suggestive of a fibrosis-like pathology. Treatment of both wild-type and telomerase-deficient mice with telomerase gene therapy prevented the onset of lung profibrotic pathologies. These findings suggest that short telomeres associated with physiological aging are at the origin of IPF and that a potential treatment for IPF based on telomerase activation would be of interest not only for patients with telomerase mutations but also for sporadic cases of IPF associated with physiological aging.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1083/jcb.202002120

Cites

99 of 99 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Telomerase deficiency and natural aging in the mouse lung leads to telomere shortening and reduction in the number of ATII and club cells. (A and B) Generation of Tert+/+ and G3 Tert−/− mice and scheme of lung tissue harvesting. (A) Heterozygous Tert+/− mice were crossed to obtain Tert+/+ and G1 Tert−/− mice, and successive crosses between G1 Tert−/− and then G2 Tert−/− mice were made to generate G3 Tert−/− mice. (B) Scheme of sacrifice and collection of lungs from Tert+/+ and G3 Tert−/− mice at different time points. (C) Representative images showing a Q-FISH for telomere spot fluorescence in ATII and club cells (Cy3Tel probe [red], SFTPC- and SCGB1A1-positive cells [green]) and nuclei stained with DAPI (blue; left and center right), SFTPC (brown, red arrowheads; center left), and SCGB1A1 (brown, green arrowheads; right) immunostainings in lung sections from Tert+/+ and G3 Tert−/− at different time points. (D–I) Quantification of mean telomere fluorescence (mean spot intensity; D and F), percentage of short telomeres in ATII and club cells corresponding to the 20th percentile of the fluorescence intensity values of controls (5-wk-old Tert+/+ mice; E and G), and SFTPC-positive ATII cells (%) and SCGB1A1-positive club cells per epithelium length (millimeters; H and I). Quantifications were performed on five different alveolar areas or bronchi in a random way. Data are expressed as mean ± SEM (n = 4 animals per group). *, P < 0.05; **, P < 0.01; ***, P < 0.001 (Shapiro–Wilk, Kruskal–Wallis, and Dunn–Sidak multiple comparison test). ns, not significant.
Figure 1. Telomerase deficiency and natural aging in the mouse lung leads to telomere shortening and reduction in the number of ATII and club cells. (A and B) Generation of Tert+/+ and G3 Tert−/− mice and scheme of lung tissue harvesting. (A) Heterozygous Tert+/− mice were crossed to obtain Tert+/+ and G1 Tert−/− mice, and successive crosses between G1 Tert−/− and then G2 Tert−/− mice were made to generate G3 Tert−/− mice. (B) Scheme of sacrifice and collection of lungs from Tert+/+ and G3 Tert−/− mice at different time points. (C) Representative images showing a Q-FISH for telomere spot fluorescence in ATII and club cells (Cy3Tel probe [red], SFTPC- and SCGB1A1-positive cells [green]) and nuclei stained with DAPI (blue; left and center right), SFTPC (brown, red arrowheads; center left), and SCGB1A1 (brown, green arrowheads; right) immunostainings in lung sections from Tert+/+ and G3 Tert−/− at different time points. (D–I) Quantification of mean telomere fluorescence (mean spot intensity; D and F), percentage of short telomeres in ATII and club cells corresponding to the 20th percentile of the fluorescence intensity values of controls (5-wk-old Tert+/+ mice; E and G), and SFTPC-positive ATII cells (%) and SCGB1A1-positive club cells per epithelium length (millimeters; H and I). Quantifications were performed on five different alveolar areas or bronchi in a random way. Data are expressed as mean ± SEM (n = 4 animals per group). *, P < 0.05; **, P < 0.01; ***, P < 0.001 (Shapiro–Wilk, Kruskal–Wallis, and Dunn–Sidak multiple comparison test). ns, not significant.CC BY-NC-SA · PubMed Central
Figure 2. Premature aging by accelerated telomere shortening and natural aging in the mouse lung result in increased fibroblast presence and activation and collagen deposition. (A) Representative images showing vimentin (brown; left) and SMA (brown; center left) immunostainings and Sirius Red (red; center right) and Masson (blue; right) stainings in lung sections from Tert+/+ and G3 Tert−/− mice at different time points. (B–E) Quantification of vimentin (fibroblast marker)–positive area per HPF (%; B), peribronchial SMA (fibroblast activation marker) –positive area (%; C), alveolar collagen content per HPF (%; D), and peribronchial collagen content (%; E). Quantifications were performed on five different alveolar areas or bronchi in a random way. Data are expressed as mean ± SEM (n = 4 animals per group). *, P < 0.05; **, P < 0.01; ***, P < 0.001 (Shapiro–Wilk, Kruskal–Wallis, and Dunn–Sidak multiple comparison test). ns, not significant.
Figure 2. Premature aging by accelerated telomere shortening and natural aging in the mouse lung result in increased fibroblast presence and activation and collagen deposition. (A) Representative images showing vimentin (brown; left) and SMA (brown; center left) immunostainings and Sirius Red (red; center right) and Masson (blue; right) stainings in lung sections from Tert+/+ and G3 Tert−/− mice at different time points. (B–E) Quantification of vimentin (fibroblast marker)–positive area per HPF (%; B), peribronchial SMA (fibroblast activation marker) –positive area (%; C), alveolar collagen content per HPF (%; D), and peribronchial collagen content (%; E). Quantifications were performed on five different alveolar areas or bronchi in a random way. Data are expressed as mean ± SEM (n = 4 animals per group). *, P < 0.05; **, P < 0.01; ***, P < 0.001 (Shapiro–Wilk, Kruskal–Wallis, and Dunn–Sidak multiple comparison test). ns, not significant.CC BY-NC-SA · PubMed Central
Figure 3. Induced-telomere shortening and natural aging increase DNA damage, apoptosis, and macrophage senescence in the mouse lung. (A) Representative immunostainings for alveolar γ-H2AX (brown, green arrowheads; left), activated C3 (brown, orange arrowheads; center left), p16 (brown, blue arrowheads; center right), and F4/80 and p16 (purple and brown, respectively; red arrowheads indicate double F4/80-p16-positive AMs; right) in Tert+/+ and G3 Tert−/− mice at different time points. (B–D) Quantification of alveolar γ-H2AX–positive (B) and C3- positive (C), and p16-positive (D) cells, and double F4/80-p16-positive AMs (%; E). Quantifications were performed on five different alveolar areas in a random way. Data are expressed as mean ± SEM (n = 4 animals per group). *, P < 0.05; **, P < 0.01; ***, P < 0.001 (Shapiro–Wilk, Kruskal–Wallis, and Dunn–Sidak multiple comparison test). ns, not significant.
Figure 3. Induced-telomere shortening and natural aging increase DNA damage, apoptosis, and macrophage senescence in the mouse lung. (A) Representative immunostainings for alveolar γ-H2AX (brown, green arrowheads; left), activated C3 (brown, orange arrowheads; center left), p16 (brown, blue arrowheads; center right), and F4/80 and p16 (purple and brown, respectively; red arrowheads indicate double F4/80-p16-positive AMs; right) in Tert+/+ and G3 Tert−/− mice at different time points. (B–D) Quantification of alveolar γ-H2AX–positive (B) and C3- positive (C), and p16-positive (D) cells, and double F4/80-p16-positive AMs (%; E). Quantifications were performed on five different alveolar areas in a random way. Data are expressed as mean ± SEM (n = 4 animals per group). *, P < 0.05; **, P < 0.01; ***, P < 0.001 (Shapiro–Wilk, Kruskal–Wallis, and Dunn–Sidak multiple comparison test). ns, not significant.CC BY-NC-SA · PubMed Central
Figure 4. Premature telomere shortening and natural aging reduce the proliferation of ATII cells, macrophages, and club cells and increase the differentiation of club cells. (A) Representative immunostainings for SFTPC (purple), F4/80(brown), and Ki67 (blue; orange and blue arrowheads indicate double SFTPC-Ki67– and F4/80-Ki67–positive cells, respectively; left); SCGB1A1 (purple) and Ki67 (blue and green arrowheads indicate double SCGB1A1-Ki67–positive club cells; center), and SCGB1A1 (blue) and SOX2 (brown; red arrowheads indicate double SCGB1A1-SOX2–positive club cells; right) in Tert+/+ and G3 Tert−/− mice at different time points. (B–E) Quantification of SFTPC-Ki67–positive (B), F4/80-Ki67–positive (C), SCGB1A1-Ki67–positive (D), and SCGB1A1-SOX2–positive (E) cells. (F–L) Changes in total lung mRNA expression levels of Tert (F) and total lung mRNA expression of Tnf (G), Il1b (H), and Il6 (I; pro-inflammatory markers) and Il4 (J), Il10 (K), and Il13 (L; anti-inflammatory markers) normalized to 18S expression, and (M–P) protein levels of TNF (M), IL-6 (N), IL-4 (O), and IL-10 (P) assessed in lung homogenates from young (5 wk) and older (61–72 wk) Tert+/+ and G3 Tert−/− mice. Quantifications were performed on five different alveolar areas or bronchi in a random way. Data are expressed as mean ± SEM (n = 4 animals per group). *, P < 0.05; **, P < 0.01; ***, P < 0.001 (Shapiro–Wilk, Kruskal–Wallis, and Dunn–Sidak multiple comparison test). ns, not significant.
Figure 4. Premature telomere shortening and natural aging reduce the proliferation of ATII cells, macrophages, and club cells and increase the differentiation of club cells. (A) Representative immunostainings for SFTPC (purple), F4/80(brown), and Ki67 (blue; orange and blue arrowheads indicate double SFTPC-Ki67– and F4/80-Ki67–positive cells, respectively; left); SCGB1A1 (purple) and Ki67 (blue and green arrowheads indicate double SCGB1A1-Ki67–positive club cells; center), and SCGB1A1 (blue) and SOX2 (brown; red arrowheads indicate double SCGB1A1-SOX2–positive club cells; right) in Tert+/+ and G3 Tert−/− mice at different time points. (B–E) Quantification of SFTPC-Ki67–positive (B), F4/80-Ki67–positive (C), SCGB1A1-Ki67–positive (D), and SCGB1A1-SOX2–positive (E) cells. (F–L) Changes in total lung mRNA expression levels of Tert (F) and total lung mRNA expression of Tnf (G), Il1b (H), and Il6 (I; pro-inflammatory markers) and Il4 (J), Il10 (K), and Il13 (L; anti-inflammatory markers) normalized to 18S expression, and (M–P) protein levels of TNF (M), IL-6 (N), IL-4 (O), and IL-10 (P) assessed in lung homogenates from young (5 wk) and older (61–72 wk) Tert+/+ and G3 Tert−/− mice. Quantifications were performed on five different alveolar areas or bronchi in a random way. Data are expressed as mean ± SEM (n = 4 animals per group). *, P < 0.05; **, P < 0.01; ***, P < 0.001 (Shapiro–Wilk, Kruskal–Wallis, and Dunn–Sidak multiple comparison test). ns, not significant.CC BY-NC-SA · PubMed Central
Figure 5. Physiological aging leads to impaired surfactant activity which is partially restored by telomerase gene therapy in both wild-type mice and telomerase-deficient mice. (A and B) Captive bubble results from Tert+/+ and G3 Tert−/− mice with increasing weeks of age. (C and D) Captive bubble results from 71–72-wk-old Tert+/+ and G3 Tert−/− mice treated with AAV9-empty or AAV9-Tert. (A and C) Top: Surface tension obtained 1 s after applying surfactant onto the air bubble (initial adsorption). Bottom: Surface tension obtained 1 s after the bubble expansion (postexpansion [PE] adsorption). (B and D) Top: Representative γ-relative area isotherms obtained under breathing-like dynamic cycles for each group tested. Bottom: Minimum and maximum γ along with the relative area of compression obtained during the 20th cycle. White bars represent Tert+/+ mice. Gray bars represent G3 Tert−/− mice. Data are expressed as mean ± SEM (n = 5–6 animals per group). *, P < 0.05; **, P < 0.01. Between different ages for each condition: One-way ANOVA with post hoc Dunn–Sidak multiple comparison test. Between different conditions within the same age: following a Shapiro–Wilk normality test, two-sample unpaired t test, or Mann–Whitney test when appropriate. γ, surface tension; max, maximum; min, minimum.
Figure 5. Physiological aging leads to impaired surfactant activity which is partially restored by telomerase gene therapy in both wild-type mice and telomerase-deficient mice. (A and B) Captive bubble results from Tert+/+ and G3 Tert−/− mice with increasing weeks of age. (C and D) Captive bubble results from 71–72-wk-old Tert+/+ and G3 Tert−/− mice treated with AAV9-empty or AAV9-Tert. (A and C) Top: Surface tension obtained 1 s after applying surfactant onto the air bubble (initial adsorption). Bottom: Surface tension obtained 1 s after the bubble expansion (postexpansion [PE] adsorption). (B and D) Top: Representative γ-relative area isotherms obtained under breathing-like dynamic cycles for each group tested. Bottom: Minimum and maximum γ along with the relative area of compression obtained during the 20th cycle. White bars represent Tert+/+ mice. Gray bars represent G3 Tert−/− mice. Data are expressed as mean ± SEM (n = 5–6 animals per group). *, P < 0.05; **, P < 0.01. Between different ages for each condition: One-way ANOVA with post hoc Dunn–Sidak multiple comparison test. Between different conditions within the same age: following a Shapiro–Wilk normality test, two-sample unpaired t test, or Mann–Whitney test when appropriate. γ, surface tension; max, maximum; min, minimum.CC BY-NC-SA · PubMed Central
Figure S1. Physiological aging leads to impaired surfactant activity in wild-type mice, and this is anticipated in telomerase-deficient mice. Interfacial film stability and WB of hydrophobic surfactant proteins from Tert+/+ and G3 Tert−/− mice with increasing weeks of age. (A) Surface tension obtained after hitting five-times-compressed surfactant membranes to test their stability. (B) SP-B and SP-C bands obtained by performing WB analysis in reducing conditions, loading the same amount of PC for each sample. Densitometry analysis was performed using as reference the most intense band among the samples tested within each run. White bars represent Tert+/+ mice. Gray bars represent G3 Tert−/− mice. Data are expressed as mean ± SEM (n = 4–6 animals per group). *, P < 0.05; **, P < 0.01 between different ages for each condition using one-way ANOVA with post hoc Dunn–Sidak multiple comparison test or between different conditions within the same age following a Shapiro–Wilk normality test, two-sample unpaired t test, or Mann–Whitney test when appropriate. γ, surface tension; A.D.U., arbitrary densitometry units.
Figure S1. Physiological aging leads to impaired surfactant activity in wild-type mice, and this is anticipated in telomerase-deficient mice. Interfacial film stability and WB of hydrophobic surfactant proteins from Tert+/+ and G3 Tert−/− mice with increasing weeks of age. (A) Surface tension obtained after hitting five-times-compressed surfactant membranes to test their stability. (B) SP-B and SP-C bands obtained by performing WB analysis in reducing conditions, loading the same amount of PC for each sample. Densitometry analysis was performed using as reference the most intense band among the samples tested within each run. White bars represent Tert+/+ mice. Gray bars represent G3 Tert−/− mice. Data are expressed as mean ± SEM (n = 4–6 animals per group). *, P < 0.05; **, P < 0.01 between different ages for each condition using one-way ANOVA with post hoc Dunn–Sidak multiple comparison test or between different conditions within the same age following a Shapiro–Wilk normality test, two-sample unpaired t test, or Mann–Whitney test when appropriate. γ, surface tension; A.D.U., arbitrary densitometry units.CC BY-NC-SA · PubMed Central
Figure 6. Telomerase gene therapy in the mouse lung results in telomere elongation and increased number of ATII and club cells. (A) Experimental protocol for the administration of AAV9-Tert and AAV9-empty virus. 27–30-wk-old Tert+/+ and G3 Tert−/− mice were administered with 2E12vg of AAV9-Tert and AAV9-empty virus by intravenous tail injection. Animals were sacrificed 21 wk later for lung tissue harvesting. (B) Total lung mRNA levels of Tert normalized to 18S expression in AAV9-empty– and AAV9-Tert–treated animals. (C–H) Quantification of mean telomere fluorescence (mean spot intensity; C and E), percentage of short telomeres in ATII and club cells corresponding to the 20th percentile of the fluorescence intensity values of controls (5-wk-old Tert+/+ mice; D and F), and SFTPC-positive ATII cells (%) and SCGB1A1-positive club cells per epithelium length (millimeters) in AAV9-Tert– and AAV9-empty–treated mice (G and H). (I) Representative images showing a Q-FISH for telomere spot fluorescence in ATII and club cells (Cy3Tel probe [red], SFTPC- and SCGB1A1-positive cells [green], and nuclei stained with DAPI [blue]; left and center right), and SFTPC (brown, red arrowheads; center left) and SCGB1A1 (brown, green arrowheads; right) immunostainings in lung sections from Tert+/+ and G3 Tert−/− mice treated with the AAV9-Tert (upper panels) or AAV9-empty (lower panels) virus. (J–L) Changes in total lung mRNA expression levels of the surfactant markers Sftpa1, Sftpc, and Sftpd normalized to 18S expression. Quantifications were performed on five different alveolar areas or bronchi in a random way. Data are expressed as mean ± SEM (n = 4 animals per group). *, P < 0.05; **, P < 0.01; ***, P < 0.001 (Shapiro–Wilk, Kruskal–Wallis, and Dunn–Sidak multiple comparison test). ns, not significant.
Figure 6. Telomerase gene therapy in the mouse lung results in telomere elongation and increased number of ATII and club cells. (A) Experimental protocol for the administration of AAV9-Tert and AAV9-empty virus. 27–30-wk-old Tert+/+ and G3 Tert−/− mice were administered with 2E12vg of AAV9-Tert and AAV9-empty virus by intravenous tail injection. Animals were sacrificed 21 wk later for lung tissue harvesting. (B) Total lung mRNA levels of Tert normalized to 18S expression in AAV9-empty– and AAV9-Tert–treated animals. (C–H) Quantification of mean telomere fluorescence (mean spot intensity; C and E), percentage of short telomeres in ATII and club cells corresponding to the 20th percentile of the fluorescence intensity values of controls (5-wk-old Tert+/+ mice; D and F), and SFTPC-positive ATII cells (%) and SCGB1A1-positive club cells per epithelium length (millimeters) in AAV9-Tert– and AAV9-empty–treated mice (G and H). (I) Representative images showing a Q-FISH for telomere spot fluorescence in ATII and club cells (Cy3Tel probe [red], SFTPC- and SCGB1A1-positive cells [green], and nuclei stained with DAPI [blue]; left and center right), and SFTPC (brown, red arrowheads; center left) and SCGB1A1 (brown, green arrowheads; right) immunostainings in lung sections from Tert+/+ and G3 Tert−/− mice treated with the AAV9-Tert (upper panels) or AAV9-empty (lower panels) virus. (J–L) Changes in total lung mRNA expression levels of the surfactant markers Sftpa1, Sftpc, and Sftpd normalized to 18S expression. Quantifications were performed on five different alveolar areas or bronchi in a random way. Data are expressed as mean ± SEM (n = 4 animals per group). *, P < 0.05; **, P < 0.01; ***, P < 0.001 (Shapiro–Wilk, Kruskal–Wallis, and Dunn–Sidak multiple comparison test). ns, not significant.CC BY-NC-SA · PubMed Central
Figure 7. AAV9-Tert treatment reduces fibroblast presence and activation and collagen deposition in the mouse lung. (A) Representative images of vimentin (brown; left) and SMA (brown; center left) immunostainings and Sirius Red (red; center right) and Masson (blue; right) stainings in lung sections from Tert+/+ and G3 Tert−/− mice treated with the AAV9-Tert (upper panels) or AAV9-empty (lower panels) virus. (B–E) Quantification of vimentin-positive (fibroblast marker) area per HPF (%; B), peribronchial SMA-positive (fibroblast activation marker) area (%; C), alveolar collagen content per HPF (%; D), and peribronchial collagen content (%; E). Quantifications were performed on five different alveolar areas or bronchi in a random way. Data are expressed as mean ± SEM (n = 4 animals per group). **, P < 0.01; ***, P < 0.001 (Shapiro–Wilk, Kruskal–Wallis and Dunn–Sidak multiple comparison test). ns, not significant.
Figure 7. AAV9-Tert treatment reduces fibroblast presence and activation and collagen deposition in the mouse lung. (A) Representative images of vimentin (brown; left) and SMA (brown; center left) immunostainings and Sirius Red (red; center right) and Masson (blue; right) stainings in lung sections from Tert+/+ and G3 Tert−/− mice treated with the AAV9-Tert (upper panels) or AAV9-empty (lower panels) virus. (B–E) Quantification of vimentin-positive (fibroblast marker) area per HPF (%; B), peribronchial SMA-positive (fibroblast activation marker) area (%; C), alveolar collagen content per HPF (%; D), and peribronchial collagen content (%; E). Quantifications were performed on five different alveolar areas or bronchi in a random way. Data are expressed as mean ± SEM (n = 4 animals per group). **, P < 0.01; ***, P < 0.001 (Shapiro–Wilk, Kruskal–Wallis and Dunn–Sidak multiple comparison test). ns, not significant.CC BY-NC-SA · PubMed Central
Figure 8. Telomerase gene therapy ameliorates DNA damage, apoptosis, and macrophage senescence in the mouse lung. (A) Representative immunostainings for alveolar γ-H2AX (brown, green arrowheads; left), activated C3 (brown, orange arrowheads; center left), p16 (brown, blue arrowheads; center right), and F4/80 and p16 (purple and brown, respectively; red arrowheads indicate double F4/80-p16–positive AMs; right) in lungs of Tert+/+ and G3 Tert−/− mice treated with the AAV9-Tert (upper panels) or AAV9-empty (lower panels) virus. (B–E) Quantification of alveolar γ-H2AX–positive (B), C3-positive (C), and p16-positive (D) cells and double F4/80-p16–positive AMs (%; E). Quantifications were performed on five different alveolar areas in a random way. Data are expressed as mean ± SEM (n = 4–5 animals per group). *, P < 0.05; **, P < 0.01; ***, P < 0.001 (Shapiro–Wilk, Kruskal–Wallis and Dunn–Sidak multiple comparison test). ns, not significant.
Figure 8. Telomerase gene therapy ameliorates DNA damage, apoptosis, and macrophage senescence in the mouse lung. (A) Representative immunostainings for alveolar γ-H2AX (brown, green arrowheads; left), activated C3 (brown, orange arrowheads; center left), p16 (brown, blue arrowheads; center right), and F4/80 and p16 (purple and brown, respectively; red arrowheads indicate double F4/80-p16–positive AMs; right) in lungs of Tert+/+ and G3 Tert−/− mice treated with the AAV9-Tert (upper panels) or AAV9-empty (lower panels) virus. (B–E) Quantification of alveolar γ-H2AX–positive (B), C3-positive (C), and p16-positive (D) cells and double F4/80-p16–positive AMs (%; E). Quantifications were performed on five different alveolar areas in a random way. Data are expressed as mean ± SEM (n = 4–5 animals per group). *, P < 0.05; **, P < 0.01; ***, P < 0.001 (Shapiro–Wilk, Kruskal–Wallis and Dunn–Sidak multiple comparison test). ns, not significant.CC BY-NC-SA · PubMed Central
Figure 9. Treatment with AAV9-Tert restores the proliferation of AT II cells, macrophages, and club cells and reduces the differentiation of club cells. (A) Representative immunostainings for SFTPC (purple), F4/80 (brown), and Ki67 (blue; orange and blue arrowheads indicate double SFTPC-Ki67– and F4/80-Ki67–positive cells, respectively; left); SCGB1A1 (purple) and Ki67 (blue; green arrowheads indicate double SCGB1A1-Ki67–positive club cells; center); and SCGB1A1 (blue) and SOX2 (brown; red arrowheads indicate double SCGB1A1-SOX2–positive club cells; left) in lungs of Tert+/+ and G3 Tert−/− mice treated with the AAV9-Tert (upper panels) or AAV9-empty (lower panels). (B–E) Quantification of SFTPC-Ki67–positive (B), F4/80-Ki67–positive (C), SCGB1A1-Ki67–positive (D), and SCGB1A1-SOX2–positive (E) cells. (F–K) Changes in total lung mRNA expression levels of Tnf (F), Il1b (G), and Il6 (H; proinflammatory markers) and Il4 (I), Il10 (J), and Il13 (K; anti-inflammatory markers) normalized to 18S expression and (L–O) protein levels of TNF (L), IL-6 (M), IL-4 (N), and IL-10 (O) assessed in lung homogenates from AAV9-empty– and AAV9-Tert–treated animals. Quantifications were performed on five different alveolar areas or bronchi in a random way. Data are expressed as mean ± SEM (n = 4–5 animals per group). *, P < 0.05; **, P < 0.01; ***, P < 0.001 (Shapiro–Wilk, Kruskal–Wallis, and Dunn–Sidak multiple comparison test). ns, not significant.
Figure 9. Treatment with AAV9-Tert restores the proliferation of AT II cells, macrophages, and club cells and reduces the differentiation of club cells. (A) Representative immunostainings for SFTPC (purple), F4/80 (brown), and Ki67 (blue; orange and blue arrowheads indicate double SFTPC-Ki67– and F4/80-Ki67–positive cells, respectively; left); SCGB1A1 (purple) and Ki67 (blue; green arrowheads indicate double SCGB1A1-Ki67–positive club cells; center); and SCGB1A1 (blue) and SOX2 (brown; red arrowheads indicate double SCGB1A1-SOX2–positive club cells; left) in lungs of Tert+/+ and G3 Tert−/− mice treated with the AAV9-Tert (upper panels) or AAV9-empty (lower panels). (B–E) Quantification of SFTPC-Ki67–positive (B), F4/80-Ki67–positive (C), SCGB1A1-Ki67–positive (D), and SCGB1A1-SOX2–positive (E) cells. (F–K) Changes in total lung mRNA expression levels of Tnf (F), Il1b (G), and Il6 (H; proinflammatory markers) and Il4 (I), Il10 (J), and Il13 (K; anti-inflammatory markers) normalized to 18S expression and (L–O) protein levels of TNF (L), IL-6 (M), IL-4 (N), and IL-10 (O) assessed in lung homogenates from AAV9-empty– and AAV9-Tert–treated animals. Quantifications were performed on five different alveolar areas or bronchi in a random way. Data are expressed as mean ± SEM (n = 4–5 animals per group). *, P < 0.05; **, P < 0.01; ***, P < 0.001 (Shapiro–Wilk, Kruskal–Wallis, and Dunn–Sidak multiple comparison test). ns, not significant.CC BY-NC-SA · PubMed Central
Figure S2. Telomerase gene therapy prevents age-related worsening in surfactant activity in wild-type and telomerase-deficient mice. Membrane stability and WB of hydrophobic surfactant proteins from 71–72-wk-old Tert+/+ and G3 Tert−/− mice treated with AAV9-empty or AAV9-Tert. (A) Surface tension obtained after hitting five-times-compressed surfactant membranes to test their stability. (B) SP-B and SP-C bands obtained by performing WB analysis in reducing conditions, loading the same amount of PC for each sample. Densitometry analysis was performed using as reference the most intense band among the samples tested within each run. White bars represent Tert+/+ mice. Gray bars represent G3 Tert−/− mice. Data are expressed as mean ± SEM (n = 3–5 animals per group). *, P < 0.05 between different conditions following a Shapiro–Wilk normality test, two-sample unpaired t test, or Mann–Whitney test when appropriate. γ, surface tension; A.D.U., arbitrary densitometry units.
Figure S2. Telomerase gene therapy prevents age-related worsening in surfactant activity in wild-type and telomerase-deficient mice. Membrane stability and WB of hydrophobic surfactant proteins from 71–72-wk-old Tert+/+ and G3 Tert−/− mice treated with AAV9-empty or AAV9-Tert. (A) Surface tension obtained after hitting five-times-compressed surfactant membranes to test their stability. (B) SP-B and SP-C bands obtained by performing WB analysis in reducing conditions, loading the same amount of PC for each sample. Densitometry analysis was performed using as reference the most intense band among the samples tested within each run. White bars represent Tert+/+ mice. Gray bars represent G3 Tert−/− mice. Data are expressed as mean ± SEM (n = 3–5 animals per group). *, P < 0.05 between different conditions following a Shapiro–Wilk normality test, two-sample unpaired t test, or Mann–Whitney test when appropriate. γ, surface tension; A.D.U., arbitrary densitometry units.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 99 references

Research works printed but not linked: 1

  1. Pardo, 2017, Fibroblast Senescence and Apoptosis, Ajrcmb, 56, 145

Cited by

Metadata

Authors
Piñeiro-Hermida, S., Autilio, C., Martínez, P., Bosch, F., Pérez-Gil, J., & Blasco, M. A.
Affiliations
  • Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre, Madrid, Spain 1
  • Universidad Complutense de Madrid (ES)
  • Spanish National Cancer Research Centre (ES)
  • Universitat Autònoma de Barcelona (ES)
  • Department of Biochemistry and Molecular Biology, Research Institute “Hospital 12 de Octubre (imas12),” Complutense University, Madrid, Spain 2
Venue
Journal of Cell Biology
Published
2020-08-10
Volume
219
Issue
10
ISSN
  • 0021-9525 (ISSN-L)
  • 1540-8140
OpenAlex
W3048397235
Cited by
60
References
99
Citations by year
2026: 10 · 2025: 9 · 2024: 7 · 2023: 9 · 2022: 10 · 2021: 12 · 2020: 3
FWCI
5.11
Type
journal article
Language
en
Open access
Locations
  • The Journal of Cell Biology (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • Library Open Repository (Universidad Complutense Madrid) (submittedVersion, cc-by-nc-sa)
  • Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by-nc-nd)
  • RIUR (Universidad de La Rioja) (submittedVersion, other-oa)
Funders
  • Spanish Ministry of Economy and Competitiveness (SAF2013-45111-R, SAF2015-72455-EXP)
  • Comunidad de Madrid Project (S2017/BMD-3770)
  • World Cancer Research Fund (16-1177)
  • Spanish Ministry of Science and Innovation (RTI2018-094564-B-100, DTS17/ 00152, SAF2017-82623-R)
  • Regional Government of Madrid (P2018/NMT-4389)
  • Fundación Botín
  • Fundación Banco Santander
  • Instituto de Salud Carlos III
  • European Regional Development Fund
  • Spanish Estate Research Agency
  • RyPSE-CM (B2017/BMD-3770)
  • Community of Madrid
  • European Social Fund
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
Keywords
telomerase, idiopathic pulmonary fibrosis, physiological aging, telomere shortening, pulmonary fibrosis, cellular senescence, alveolar type II cells, Clara cells, fibroblast activation, collagen deposition, DNA damage
MeSH terms
Aging, Animals, Bleomycin, Disease Models, Animal, DNA Damage, Humans, Lung, Telomere, Cellular Senescence, Mice, Knockout, Telomerase, Mice, Idiopathic Pulmonary Fibrosis, Telomere Shortening

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.